Full Text
Cost Minimization Analysis of Using Pazopanib in First-Line Treatment in Patients with Metastatic Renal Cell Carcinoma

Abstract

Authors

ME Romero Prada S Celis PA Alfonso Quiñones G Acero

Back to Volume 19, Issue 7
Your browser is out-of-date

ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now

×